Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Danshen Dripping Pills for Diabetic Kidney Disease Fibrosis
ChiCTR2500107551Phase 4Not yet recruiting
- Sponsor
- General Hospital of Central Theater Command of the Chinese People's Liberation Army
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Compound Danshen in diabetic glomerulosclerosis (2 arms), sponsored by General Hospital of Central Theater Command of the Chinese People's Liberation Army. Primary endpoints: N-cadherin and E-cadherin. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
Compound Danshen
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2500107551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107551.